ZyVersa Therapeutics's total assets for Q1 2025 were $20.99B, an increase of 101774.46% from the previous quarter. ZVSA total liabilities were $12.86B for the fiscal quarter, a 106291.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.